“Sick of wait-times, ER closures, and hallway medicine:” Health Coalition and Union call on Ford to prioritize health care instead of re-election bid

OTTAWA–(BUSINESS WIRE)–In 2024, Ontario’s health care crisis reached new lows: the number of patients in hospital hallways hit a record high; ER closures broke a new threshold; the wait-list for long-term care beds peaked at 48,000, 250,000 people languished on the surgical waitlist and 2.5 million people did not have a family doctor. And yet, advocates say, instead of addressing this crisis the government is needlessly focused on an early election campaign. On Thursday, January 9, Ottawa com
Read More

Smart Meter Remote Patient Monitoring Achieves Remarkable Growth and Expansion

TAMPA, Fla.–(BUSINESS WIRE)–Smart Meter, the leading technology and infrastructure supplier to the remote patient monitoring (RPM) industry, is thrilled to announce significant milestones in its growth trajectory. Since 2022, the company has achieved a remarkable 300% increase in sales, quadrupled its commercial customer base, and over 350,000 patients currently have Smart Meter solutions. To accommodate this rapid growth, Smart Meter has moved into a new 25,000 square foot logistics, network
Read More

MDaudit Announces Strategic Growth Investment from Bregal Sagemount and Primus Capital

WALTHAM, Mass.–(BUSINESS WIRE)–MDaudit, a premier provider of billing, coding compliance and revenue integrity software for health systems, hospitals, and provider groups, announced a strategic growth investment from Bregal Sagemount (“Sagemount”), a leading growth-focused private equity firm, and Primus Capital (“Primus”), the company’s existing investor. Terms of the transaction were not disclosed. MDaudit, headquartered in Waltham, MA, specializes in delivering high-quality, customer-centr
Read More

Arrivo BioVentures Announces Positive Results from qEEG and BNA™ Study of SP-624 on Neural Brain Activity Related to Depression and Cognition

MORRISVILLE, N.C.–(BUSINESS WIRE)–Arrivo BioVentures today announced positive data from its SP-624-103 study evaluating the impact of SP-624’s novel epigenetic mechanism of action on neurological pathways. The findings provide insights into the potential antidepressant and cognitive effects of SP-624, a SIRT6 activator that may be the first treatment specifically for females with Major Depression based on previous studies. Arrivo’s SP-624-103 study is a double blind, placebo-controlled study
Read More

NashBio Announces New Suite of Strategic Data Solutions to Accelerate Life Science Research and Development

NASHVILLE, Tenn.–(BUSINESS WIRE)–Nashville Biosciences LLC (NashBio), a leading real-world, multi-omics data company, today announced the launch of multiple next-generation, real-world data (RWD) solutions, including a research platform and therapeutic area collections over the next 6 months. These advancements will deliver unprecedented access to deidentified electronic health record (EHR) and linked genomic data, empowering life science researchers, pharmaceutical companies, and biotech inn
Read More

Parse Biosciences vervierfacht die Multiplexing-Fähigkeiten für Evercode WT Mega Kits

SEATTLE–(BUSINESS WIRE)–Parse Biosciences, ein führender Anbieter von zugänglichen und skalierbaren Einzelzell-Sequenzierungslösungen, kündigte heute eine bedeutende Erweiterung der Funktionalität seines Evercode™ WT Mega Kit an. Forscher können nun bis zu 384 Proben und 1 Million Zellen in einem einzigen Durchlauf analysieren, was neue Möglichkeiten für Studien mit hohem Durchsatz eröffnet. Während sich die Einzelzelltechnologien stetig weiterentwickelt haben, stoßen viele immer noch an ihre
Read More

Preterm birth study finds maternal biomarker test significantly reduces neonatal morbidities, improves neonatal outcomes

Preterm birth―defined as delivery before the 37th week of pregnancy—is one of the leading causes of infant deaths in the United States. Babies born prematurely are also at an increased risk of having serious health problems. Yet despite advancements in many areas of obstetrics, little progress has been made to reduce the number of preterm births or improve neonatal outcomes. For the third consecutive year, the March of Dimes Annual Report Card has given the United States a D+ for the country’s persistently high preterm birth rate.
Read More

CatalYm Appoints Scott Clarke CEO as Company Initiates Global Phase 2b Clinical Development Program for Visugromab

MUNICH & SAN FRANCISCO–(BUSINESS WIRE)–CatalYm today announced the appointment of Scott Clarke as Chief Executive Officer. Mr. Clarke brings over two decades of executive leadership experience in driving company growth, developing products, and shaping and executing transactions in the biopharmaceutical industry. He takes the helm as CatalYm enters a new stage of corporate and clinical development, including the initiation of a broad Phase 2b program for its lead candidate, visugromab, in non
Read More
Top